APO Research
Talk to an analyst

APO RESEARCH · REPORT

Alinia (nitazoxanide)

Nitazoxanide, sold under the brand name Alinia among others, Nitazoxanide is an antiprotozoal medicine that treats infections caused by protozoa (single-cell parasites that live in moist places such as lakes, streams, and soil). Nitazoxanide is used to treat diarrhea caused by Giardia or Cryptosporidium. These conditions are sometimes called "Traveler's diarrhea." Nitazoxanide is used in adults and children who are at least 1 year old.

Explore the product
View pricing & licenses

Product & engineering

Understand the product.

Nitazoxanide, sold under the brand name Alinia among others, Nitazoxanide is an antiprotozoal medicine that treats infections caused by protozoa (single-cell parasites that live in moist places such as lakes, streams, and soil). Nitazoxanide is used to treat diarrhea caused by Giardia or Cryptosporidium. These conditions are sometimes called "Traveler's diarrhea." Nitazoxanide is used in adults and children who are at least 1 year old.

Selected research

Industry Growth & Trends

Global Alinia (nitazoxanide) Industry Growth and Trends Forecast to 2032

30 December 202577 pages

Choose your research edition.

Industry ResearchAlinia (nitazoxanide) Industry Research Report 2026113 pages · $2,950 USDIndustry Growth & TrendsGlobal Alinia (nitazoxanide) Industry Growth and Trends Forecast to 203277 pages · $3,450 USDMarket StructureGlobal Alinia (nitazoxanide) Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032178 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Alinia (nitazoxanide) Market Outlook and Growth Opportunities 2026195 pages · $4,250 USDMarket Analysis & ForecastGlobal Alinia (nitazoxanide) Market Analysis and Forecast 2026-2032192 pages · $4,950 USD

Market perspective

Nitazoxanide, sold under the brand name Alinia among others, Nitazoxanide is an antiprotozoal medicine that treats infections caused by protozoa (single-cell parasites that live in moist places such as lakes, streams, and soil). Nitazoxanide is used to treat diarrhea caused by Giardia or Cryptosporidium. These conditions are sometimes called "Traveler's diarrhea." Nitazoxanide is used in adults and children who are at least 1 year old.

The key players of Alinia (nitazoxanide) include Romark Laboratories, Chugai Pharmaceutical, Lupin etc. The top three players of Alinia (nitazoxanide) account for approximately 45% of the total global market. Asia-Pacific is the largest consumer market of Alinia (nitazoxanide) accounting for about 45% followed by South America and Europe. In terms of Type, Tablets is the largest segment, with a share about 99%. And in terms of Application, the largest application is Hospital followed by Retail Pharmacy.

Report Scope

Read the full market overview

This report provides a structured, data-driven view of the global Alinia (nitazoxanide) market, combining harmonized quantitative metrics with targeted qualitative insight to support business and growth strategy, market positioning, and capital allocation.

The Alinia (nitazoxanide) market size, estimates, and forecasts are presented in terms of sales volume (K Units) and revenue (US$ million), with 2025 as the base year and historical and forecast data for 2021-2032. The report segments the global Alinia (nitazoxanide) market by Type, Application, region/country, and company, provides regional market sizes at the segment level, profiles the competitive landscape and key players and their market ranks, and reviews technology trends and new product developments relevant to Alinia (nitazoxanide).

Key Companies & Market Share Insights

This section analyzes the strategies and performance of leading manufacturers in the global Alinia (nitazoxanide) market, including portfolio focus, innovation and product development, mergers and acquisitions, collaborations, and geographic expansion used to sustain or enhance competitive positions. It also summarizes recent corporate developments and key financial indicators and provides global revenue, price, and sales volume data by manufacturer for 2020-2025, enabling benchmarking of scale, pricing, and market share and supporting assessment of market concentration through indicators such as CR5 and CR10.

Alinia (nitazoxanide) Market by Company

Romark Laboratories

Chugai Pharmaceutical

Lupin

Alinia (nitazoxanide) Segment by Type

Tablets

Oral Suspension

Alinia (nitazoxanide) Segment by Application

Retail Pharmacy

Hospital

Others

Alinia (nitazoxanide) Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Key Drivers & Barriers

High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Alinia (nitazoxanide) market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Alinia (nitazoxanide) and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Alinia (nitazoxanide).

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the study scope of this report, executive summary of market segments by type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of Alinia (nitazoxanide) manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.

Chapter 4: Sales, revenue of Alinia (nitazoxanide) in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.

Chapter 5: Introduces market segments by application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 7, 8, 9, 10 and 11: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.

Chapter 12: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics.

Chapter 13: Concluding Insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Major Company of Tablets Table 2. Major Company of Oral Suspension Table 3. Global Alinia (nitazoxanide) Sales by Type (2021 VS 2025 VS 2032) & (US$ Million) Table 4. Global Alinia (nitazoxanide) Sales by Type (2021-2026) & (K Units) Table 5. Global Alinia (nitazoxanide) Sales Market Share in Volume by Type (2021-2026) Table 6. Global Alinia (nitazoxanide) Sales by Type (2021-2026) & (US$ Million) Table 7. Global Alinia (nitazoxanide) Sales Market Share in Value by Type (2021-2026) Table 8. Global Alinia (nitazoxanide) Price by Type (2021-2026) & (US$/Unit) Table 9. Global Alinia (nitazoxanide) Sales by Type (2027-2032) & (K Units) Table 10. Global Alinia (nitazoxanide) Sales Market Share in Volume by Type (2027-2032) Table 11. Global Alinia (nitazoxanide) Sales by Type (2027-2032) & (US$ Million) Table 12. Global Alinia (nitazoxanide) Sales Market Share in Value by Type (2027-2032) Table 13. Global Alinia (nitazoxanide) Price by Type (2027-2032) & (US$/Unit) Table 14. North America Alinia (nitazoxanide) Sales by Type (2021-2026) & (K Units) Table 15. North America Alinia (nitazoxanide) Sales by Type (2021-2026) & (US$ Million) Table 16. Europe Alinia (nitazoxanide) Sales by Type (2021-2026) & (K Units) Table 17. Europe Alinia (nitazoxanide) Sales by Type (2021-2026) & (US$ Million) Table 18. Asia-Pacific Alinia (nitazoxanide) Sales by Type (2021-2026) & (K Units) Table 19. Asia-Pacific Alinia (nitazoxanide) Sales by Type (2021-2026) & (US$ Million) Table 20. Latin America Alinia (nitazoxanide) Sales by Type (2021-2026) & (K Units) Table 21. Latin America Alinia (nitazoxanide) Sales by Type (2021-2026) & (US$ Million) Table 22. Middle East and Africa Alinia (nitazoxanide) Sales by Type (2021-2026) & (K Units) Table 23. Middle East and Africa Alinia (nitazoxanide) Sales by Type (2021-2026) & (US$ Million) Table 24. Alinia (nitazoxanide) Industry Trends Table 25. Alinia (nitazoxanide) Industry Drivers Table 26. Alinia (nitazoxanide) Industry Opportunities and Challenges Table 27. Alinia (nitazoxanide) Industry Restraints Table 28. Global Alinia (nitazoxanide) Sales Revenue by Company (US$ Million) & (2021-2026) Table 29. Global Alinia (nitazoxanide) Revenue Market Share by Company (2021-2026) Table 30. Global Alinia (nitazoxanide) Sales by Company (2021-2026) & (K Units) Table 31. Global Alinia (nitazoxanide) Sales Share by Company (2021-2026) Table 32. Global Alinia (nitazoxanide) Market Price by Company (2021-2026) & (US$/Unit) Table 33. Global Alinia (nitazoxanide) Industry Company Ranking, 2024 VS 2025 VS 2026 Table 34. Global Alinia (nitazoxanide) Major Company Production Sites and Headquarters Table 35. Global Alinia (nitazoxanide) Company, Product Type & Application Table 36. Global Alinia (nitazoxanide) Company Establishment Date Table 37. Global Company Market Concentration Ratio (CR5 and HHI) Table 38. Global Alinia (nitazoxanide) by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 39. Global Alinia (nitazoxanide) Market Size Comparison by Region (US$ Million): 2021 VS 2025 VS 2032 Table 40. Global Alinia (nitazoxanide) Sales by Region (2021-2026) & (K Units) Table 41. Global Alinia (nitazoxanide) Sales Market Share in Volume by Region (2021-2026) Table 42. Global Alinia (nitazoxanide) Sales by Region (2021-2026) & (US$ Million) Table 43. Global Alinia (nitazoxanide) Sales Market Share in Value by Region (2021-2026) Table 44. Global Alinia (nitazoxanide) Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 45. Global Alinia (nitazoxanide) Sales by Region (2027-2032) & (K Units) Table 46. Global Alinia (nitazoxanide) Sales Market Share in Volume by Region (2027-2032) Table 47. Global Alinia (nitazoxanide) Sales by Region (2027-2032) & (US$ Million) Table 48. Global Alinia (nitazoxanide) Sales Market Share in Value by Region (2027-2032) Table 49. Global Alinia (nitazoxanide) Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2027-2032) Table 50. Global Alinia (nitazoxanide) Sales by Application (2021 VS 2025 VS 2032) & (US$ Million) Table 51. Global Alinia (nitazoxanide) Sales by Application (2021-2026) & (K Units) Table 52. Global Alinia (nitazoxanide) Sales Market Share in Volume by Application (2021-2026) Table 53. Global Alinia (nitazoxanide) Sales by Application (2021-2026) & (US$ Million) Table 54. Global Alinia (nitazoxanide) Sales Market Share in Value by Application (2021-2026) Table 55. Global Alinia (nitazoxanide) Price by Application (2021-2026) & (US$/Unit) Table 56. Global Alinia (nitazoxanide) Sales by Application (2027-2032) & (K Units) Table 57. Global Alinia (nitazoxanide) Sales Market Share in Volume by Application (2027-2032) Table 58. Global Alinia (nitazoxanide) Sales by Application (2027-2032) & (US$ Million) Table 59. Global Alinia (nitazoxanide) Sales Market Share in Value by Application (2027-2032) Table 60. Global Alinia (nitazoxanide) Price by Application (2027-2032) & (US$/Unit) Table 61. North America Alinia (nitazoxanide) Sales by Application (2021-2026) & (K Units) Table 62. North America Alinia (nitazoxanide) Sales by Application (2021-2026) & (US$ Million) Table 63. Europe Alinia (nitazoxanide) Sales by Application (2021-2026) & (K Units) Table 64. Europe Alinia (nitazoxanide) Sales by Application (2021-2026) & (US$ Million) Table 65. Asia-Pacific Alinia (nitazoxanide) Sales by Application (2021-2026) & (K Units) Table 66. Asia-Pacific Alinia (nitazoxanide) Sales by Application (2021-2026) & (US$ Million) Table 67. Latin America Alinia (nitazoxanide) Sales by Application (2021-2026) & (K Units) Table 68. Latin America Alinia (nitazoxanide) Sales by Application (2021-2026) & (US$ Million) Table 69. Middle East and Africa Alinia (nitazoxanide) Sales by Application (2021-2026) & (K Units) Table 70. Middle East and Africa Alinia (nitazoxanide) Sales by Application (2021-2026) & (US$ Million) Table 71. Romark Laboratories Company Information Table 72. Romark Laboratories Business Overview Table 73. Romark Laboratories Alinia (nitazoxanide) Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 74. Romark Laboratories Alinia (nitazoxanide) Product Portfolio Table 75. Romark Laboratories Recent Development Table 76. Chugai Pharmaceutical Company Information Table 77. Chugai Pharmaceutical Business Overview Table 78. Chugai Pharmaceutical Alinia (nitazoxanide) Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 79. Chugai Pharmaceutical Alinia (nitazoxanide) Product Portfolio Table 80. Chugai Pharmaceutical Recent Development Table 81. Lupin Company Information Table 82. Lupin Business Overview Table 83. Lupin Alinia (nitazoxanide) Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 84. Lupin Alinia (nitazoxanide) Product Portfolio Table 85. Lupin Recent Development Table 86. North America Alinia (nitazoxanide) Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 87. North America Alinia (nitazoxanide) Sales by Country (2021-2026) & (K Units) Table 88. North America Alinia (nitazoxanide) Sales Market Share by Country (2021-2026) Table 89. North America Alinia (nitazoxanide) Sales Forecast by Country (2027-2032) & (K Units) Table 90. North America Alinia (nitazoxanide) Sales Market Share Forecast by Country (2027-2032) Table 91. North America Alinia (nitazoxanide) Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 92. North America Alinia (nitazoxanide) Market Size by Country (2021-2026) & (US$ Million) Table 93. North America Alinia (nitazoxanide) Market Share by Country (2021-2026) Table 94. North America Alinia (nitazoxanide) Market Size Forecast by Country (2027-2032) & (US$ Million) Table 95. North America Alinia (nitazoxanide) Market Share Forecast by Country (2027-2032) Table 96. Europe Alinia (nitazoxanide) Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 97. Europe Alinia (nitazoxanide) Sales by Country (2021-2026) & (K Units) Table 98. Europe Alinia (nitazoxanide) Sales Market Share by Country (2021-2026) Table 99. Europe Alinia (nitazoxanide) Sales Forecast by Country (2027-2032) & (K Units) Table 100. Europe Alinia (nitazoxanide) Sales Market Share Forecast by Country (2027-2032) Table 101. Europe Alinia (nitazoxanide) Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 102. Europe Alinia (nitazoxanide) Market Size by Country (2021-2026) & (US$ Million) Table 103. Europe Alinia (nitazoxanide) Market Share by Country (2021-2026) Table 104. Europe Alinia (nitazoxanide) Market Size Forecast by Country (2027-2032) & (US$ Million) Table 105. Europe Alinia (nitazoxanide) Market Share Forecast by Country (2027-2032) Table 106. Asia-Pacific Alinia (nitazoxanide) Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 107. Asia-Pacific Alinia (nitazoxanide) Sales by Country (2021-2026) & (K Units) Table 108. Asia-Pacific Alinia (nitazoxanide) Sales Market Share by Country (2021-2026) Table 109. Asia-Pacific Alinia (nitazoxanide) Sales Forecast by Country (2027-2032) & (K Units) Table 110. Asia-Pacific Alinia (nitazoxanide) Sales Market Share Forecast by Country (2027-2032) Table 111. Asia-Pacific Alinia (nitazoxanide) Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 112. Asia-Pacific Alinia (nitazoxanide) Market Size by Country (2021-2026) & (US$ Million) Table 113. Asia-Pacific Alinia (nitazoxanide) Market Share by Country (2021-2026) Table 114. Asia-Pacific Alinia (nitazoxanide) Market Size Forecast by Country (2027-2032) & (US$ Million) Table 115. Asia-Pacific Alinia (nitazoxanide) Market Share Forecast by Country (2027-2032) Table 116. Latin America Alinia (nitazoxanide) Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 117. Latin America Alinia (nitazoxanide) Sales by Country (2021-2026) & (K Units) Table 118. Latin America Alinia (nitazoxanide) Sales Market Share by Country (2021-2026) Table 119. Latin America Alinia (nitazoxanide) Sales Forecast by Country (2027-2032) & (K Units) Table 120. Latin America Alinia (nitazoxanide) Sales Market Share Forecast by Country (2027-2032) Table 121. Latin America Alinia (nitazoxanide) Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 122. Latin America Alinia (nitazoxanide) Market Size by Country (2021-2026) & (US$ Million) Table 123. Latin America Alinia (nitazoxanide) Market Share by Country (2021-2026) Table 124. Latin America Alinia (nitazoxanide) Market Size Forecast by Country (2027-2032) & (US$ Million) Table 125. Latin America Alinia (nitazoxanide) Market Share Forecast by Country (2027-2032) Table 126. Middle East and Africa Alinia (nitazoxanide) Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 127. Middle East and Africa Alinia (nitazoxanide) Sales by Country (2021-2026) & (K Units) Table 128. Middle East and Africa Alinia (nitazoxanide) Sales Market Share by Country (2021-2026) Table 129. Middle East and Africa Alinia (nitazoxanide) Sales Forecast by Country (2027-2032) & (K Units) Table 130. Middle East and Africa Alinia (nitazoxanide) Sales Market Share Forecast by Country (2027-2032) Table 131. Middle East and Africa Alinia (nitazoxanide) Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 132. Middle East and Africa Alinia (nitazoxanide) Market Size by Country (2021-2026) & (US$ Million) Table 133. Middle East and Africa Alinia (nitazoxanide) Market Share by Country (2021-2026) Table 134. Middle East and Africa Alinia (nitazoxanide) Market Size Forecast by Country (2027-2032) & (US$ Million) Table 135. Middle East and Africa Alinia (nitazoxanide) Market Share Forecast by Country (2027-2032) Table 136. Key Raw Materials Table 137. Raw Materials Key Suppliers Table 138. Alinia (nitazoxanide) Distributors List Table 139. Alinia (nitazoxanide) Customers List Table 140. Research Programs/Design for This Report Table 141. Authors List of This Report Table 142. Secondary Sources Table 143. Primary Sources List of Figures Figure 1. Alinia (nitazoxanide) Image Figure 2. Global Alinia (nitazoxanide) Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Alinia (nitazoxanide) Market Size (2021-2032) & (US$ Million) Figure 4. Global Alinia (nitazoxanide) Sales (2021-2032) & (K Units) Figure 5. Tablets Image Figure 6. Global Tablets Sales YoY Growth (2021-2032) & (K Units) Figure 7. Oral Suspension Image Figure 8. Global Oral Suspension Sales YoY Growth (2021-2032) & (K Units) Figure 9. Global Alinia (nitazoxanide) Market Size Overview by Type (2021-2032) & (US$ Million) Figure 10. Global Alinia (nitazoxanide) Market Share by Type 2025 VS 2032 Figure 11. North America Alinia (nitazoxanide) Sales Market Share in Volume by Type in 2025 Figure 12. North America Alinia (nitazoxanide) Sales Market Share in Value by Type in 2025 Figure 13. Europe Alinia (nitazoxanide) Sales Market Share in Volume by Type in 2025 Figure 14. Europe Alinia (nitazoxanide) Sales Market Share in Value by Type in 2025 Figure 15. Asia-Pacific Alinia (nitazoxanide) Sales Market Share in Volume by Type in 2025 Figure 16. Asia-Pacific Alinia (nitazoxanide) Sales Market Share in Value by Type in 2025 Figure 17. Latin America Alinia (nitazoxanide) Sales Market Share in Volume by Type in 2025 Figure 18. Latin America Alinia (nitazoxanide) Sales Market Share in Value by Type in 2025 Figure 19. Middle East and Africa Alinia (nitazoxanide) Sales Market Share in Volume by Type in 2025 Figure 20. Middle East and Africa Alinia (nitazoxanide) Sales Market Share in Value by Type in 2025 Figure 21. Global Top 5 and 10 Alinia (nitazoxanide) Players Market Share by Revenue in 2025 Figure 22. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 23. Retail Pharmacy Image Figure 24. Global Retail Pharmacy Sales YoY Growth (2021-2032) & (K Units) Figure 25. Hospital Image Figure 26. Global Hospital Sales YoY Growth (2021-2032) & (K Units) Figure 27. Others Image Figure 28. Global Others Sales YoY Growth (2021-2032) & (K Units) Figure 29. Global Alinia (nitazoxanide) Market Size Overview by Application (2021-2032) & (US$ Million) Figure 30. Global Alinia (nitazoxanide) Market Share by Application 2025 VS 2032 Figure 31. North America Alinia (nitazoxanide) Sales Market Share in Volume by Application in 2025 Figure 32. North America Alinia (nitazoxanide) Sales Market Share in Value by Application in 2025 Figure 33. Europe Alinia (nitazoxanide) Sales Market Share in Volume by Application in 2025 Figure 34. Europe Alinia (nitazoxanide) Sales Market Share in Value by Application in 2025 Figure 35. Asia-Pacific Alinia (nitazoxanide) Sales Market Share in Volume by Application in 2025 Figure 36. Asia-Pacific Alinia (nitazoxanide) Sales Market Share in Value by Application in 2025 Figure 37. Latin America Alinia (nitazoxanide) Sales Market Share in Volume by Application in 2025 Figure 38. Latin America Alinia (nitazoxanide) Sales Market Share in Value by Application in 2025 Figure 39. Middle East and Africa Alinia (nitazoxanide) Sales Market Share in Volume by Application in 2025 Figure 40. Middle East and Africa Alinia (nitazoxanide) Sales Market Share in Value by Application in 2025 Figure 41. North America Alinia (nitazoxanide) Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 42. North America Alinia (nitazoxanide) Sales Share by Country: 2021 VS 2025 VS 2032 Figure 43. North America Alinia (nitazoxanide) Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 44. North America Alinia (nitazoxanide) Market Share by Country: 2021 VS 2025 VS 2032 Figure 45. Europe Alinia (nitazoxanide) Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 46. Europe Alinia (nitazoxanide) Sales Share by Country: 2021 VS 2025 VS 2032 Figure 47. Europe Alinia (nitazoxanide) Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 48. Europe Alinia (nitazoxanide) Market Share by Country: 2021 VS 2025 VS 2032 Figure 49. Asia-Pacific Alinia (nitazoxanide) Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 50. Asia-Pacific Alinia (nitazoxanide) Sales Share by Country: 2021 VS 2025 VS 2032 Figure 51. Asia-Pacific Alinia (nitazoxanide) Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 52. Asia-Pacific Alinia (nitazoxanide) Market Share by Country: 2021 VS 2025 VS 2032 Figure 53. Latin America Alinia (nitazoxanide) Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 54. Latin America Alinia (nitazoxanide) Sales Share by Country: 2021 VS 2025 VS 2032 Figure 55. Latin America Alinia (nitazoxanide) Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 56. Latin America Alinia (nitazoxanide) Market Share by Country: 2021 VS 2025 VS 2032 Figure 57. Middle East and Africa Alinia (nitazoxanide) Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 58. Middle East and Africa Alinia (nitazoxanide) Sales Share by Country: 2021 VS 2025 VS 2032 Figure 59. Middle East and Africa Alinia (nitazoxanide) Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 60. Middle East and Africa Alinia (nitazoxanide) Market Share by Country: 2021 VS 2025 VS 2032 Figure 61. Alinia (nitazoxanide) Value Chain Figure 62. Key Raw Materials Price Figure 63. Manufacturing Cost Structure Figure 64. Alinia (nitazoxanide) Production Mode & Process Figure 65. Direct Comparison with Distribution Share Figure 66. Distributors Profiles Figure 67. Years Considered Figure 68. Research Process Figure 69. Key Executives Interviewed

Scope & coverage.

Types
  • Tablets
  • Oral Suspension
Applications
  • Retail Pharmacy
  • Hospital
  • Others
Companies covered
  • Romark Laboratories
  • Chugai Pharmaceutical
  • Lupin

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.2.1 Global Alinia (nitazoxanide) Market Size Estimates and Forecasts (2021-2032)
  4. 1.2.2 Global Alinia (nitazoxanide) Sales Estimates and Forecasts (2021-2032)
  5. 1.3 Alinia (nitazoxanide) Market by Type
  6. 1.3.1 Tablets
  7. 1.3.2 Oral Suspension
  8. 1.4 Global Alinia (nitazoxanide) Market Size by Type
  9. 1.4.1 Global Alinia (nitazoxanide) Market Size Overview by Type (2021-2032)
  10. 1.4.2 Global Alinia (nitazoxanide) Historic Market Size Review by Type (2021-2026)
  11. 1.4.3 Global Alinia (nitazoxanide) Forecasted Market Size by Type (2027-2032)
  12. 1.5 Key Regions Market Size by Type
  13. 1.5.1 North America Alinia (nitazoxanide) Sales Breakdown by Type (2021-2026)
  14. 1.5.2 Europe Alinia (nitazoxanide) Sales Breakdown by Type (2021-2026)
  15. 1.5.3 Asia-Pacific Alinia (nitazoxanide) Sales Breakdown by Type (2021-2026)
  16. 1.5.4 South America Alinia (nitazoxanide) Sales Breakdown by Type (2021-2026)
  17. 1.5.5 Middle East and Africa Alinia (nitazoxanide) Sales Breakdown by Type (2021-2026)
2 Global Market Dynamics
  1. 2.1 Alinia (nitazoxanide) Industry Trends
  2. 2.2 Alinia (nitazoxanide) Industry Drivers
  3. 2.3 Alinia (nitazoxanide) Industry Opportunities and Challenges
  4. 2.4 Alinia (nitazoxanide) Industry Restraints
3 Market Competitive Landscape by Company
  1. 3.1 Global Top Players by Alinia (nitazoxanide) Revenue (2021-2026)
  2. 3.2 Global Top Players by Alinia (nitazoxanide) Sales (2021-2026)
  3. 3.3 Global Top Players by Alinia (nitazoxanide) Price (2021-2026)
  4. 3.4 Global Alinia (nitazoxanide) Industry Company Ranking, 2024 VS 2025 VS 2026
  5. 3.5 Global Alinia (nitazoxanide) Major Company Production Sites & Headquarters
  6. 3.6 Global Alinia (nitazoxanide) Company, Product Type & Application
  7. 3.7 Global Alinia (nitazoxanide) Company Establishment Date
  8. 3.8 Market Competitive Analysis
  9. 3.8.1 Global Alinia (nitazoxanide) Market CR5 and HHI
  10. 3.8.2 Global Top 5 and 10 Alinia (nitazoxanide) Players Market Share by Revenue in 2025
  11. 3.8.3 2025 Alinia (nitazoxanide) Tier 1, Tier 2, and Tier 3
4 Alinia (nitazoxanide) Regional Status and Outlook
  1. 4.1 Global Alinia (nitazoxanide) Market Size and CAGR by Region: 2021 VS 2025 VS 2032
  2. 4.2 Global Alinia (nitazoxanide) Historic Market Size by Region
  3. 4.2.1 Global Alinia (nitazoxanide) Sales in Volume by Region (2021-2026)
  4. 4.2.2 Global Alinia (nitazoxanide) Sales in Value by Region (2021-2026)
  5. 4.2.3 Global Alinia (nitazoxanide) Sales (Volume & Value), Price and Gross Margin (2021-2026)
  6. 4.3 Global Alinia (nitazoxanide) Forecasted Market Size by Region
  7. 4.3.1 Global Alinia (nitazoxanide) Sales in Volume by Region (2027-2032)
  8. 4.3.2 Global Alinia (nitazoxanide) Sales in Value by Region (2027-2032)
  9. 4.3.3 Global Alinia (nitazoxanide) Sales (Volume & Value), Price and Gross Margin (2027-2032)
5 Alinia (nitazoxanide) by Application
  1. 5.1 Alinia (nitazoxanide) Market by Application
  2. 5.1.1 Retail Pharmacy
  3. 5.1.2 Hospital
  4. 5.1.3 Others
  5. 5.2 Global Alinia (nitazoxanide) Market Size by Application
  6. 5.2.1 Global Alinia (nitazoxanide) Market Size Overview by Application (2021-2032)
  7. 5.2.2 Global Alinia (nitazoxanide) Historic Market Size Review by Application (2021-2026)
  8. 5.2.3 Global Alinia (nitazoxanide) Forecasted Market Size by Application (2027-2032)
  9. 5.3 Key Regions Market Size by Application
  10. 5.3.1 North America Alinia (nitazoxanide) Sales Breakdown by Application (2021-2026)
  11. 5.3.2 Europe Alinia (nitazoxanide) Sales Breakdown by Application (2021-2026)
  12. 5.3.3 Asia-Pacific Alinia (nitazoxanide) Sales Breakdown by Application (2021-2026)
  13. 5.3.4 South America Alinia (nitazoxanide) Sales Breakdown by Application (2021-2026)
  14. 5.3.5 Middle East and Africa Alinia (nitazoxanide) Sales Breakdown by Application (2021-2026)
6 Company Profiles
  1. 6.1 Romark Laboratories
  2. 6.1.1 Romark Laboratories Company Information
  3. 6.1.2 Romark Laboratories Business Overview
  4. 6.1.3 Romark Laboratories Alinia (nitazoxanide) Sales, Revenue and Gross Margin (2021-2026)
  5. 6.1.4 Romark Laboratories Alinia (nitazoxanide) Product Portfolio
  6. 6.1.5 Romark Laboratories Recent Developments
  7. 6.2 Chugai Pharmaceutical
  8. 6.2.1 Chugai Pharmaceutical Company Information
  9. 6.2.2 Chugai Pharmaceutical Business Overview
  10. 6.2.3 Chugai Pharmaceutical Alinia (nitazoxanide) Sales, Revenue and Gross Margin (2021-2026)
  11. 6.2.4 Chugai Pharmaceutical Alinia (nitazoxanide) Product Portfolio
  12. 6.2.5 Chugai Pharmaceutical Recent Developments
  13. 6.3 Lupin
  14. 6.3.1 Lupin Company Information
  15. 6.3.2 Lupin Business Overview
  16. 6.3.3 Lupin Alinia (nitazoxanide) Sales, Revenue and Gross Margin (2021-2026)
  17. 6.3.4 Lupin Alinia (nitazoxanide) Product Portfolio
  18. 6.3.5 Lupin Recent Developments
7 North America by Country
  1. 7.1 North America Alinia (nitazoxanide) Sales by Country
  2. 7.1.1 North America Alinia (nitazoxanide) Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 7.1.2 North America Alinia (nitazoxanide) Sales by Country (2021-2026)
  4. 7.1.3 North America Alinia (nitazoxanide) Sales Forecast by Country (2027-2032)
  5. 7.2 North America Alinia (nitazoxanide) Market Size by Country
  6. 7.2.1 North America Alinia (nitazoxanide) Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 7.2.2 North America Alinia (nitazoxanide) Market Size by Country (2021-2026)
  8. 7.2.3 North America Alinia (nitazoxanide) Market Size Forecast by Country (2027-2032)
8 Europe by Country
  1. 8.1 Europe Alinia (nitazoxanide) Sales by Country
  2. 8.1.1 Europe Alinia (nitazoxanide) Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 8.1.2 Europe Alinia (nitazoxanide) Sales by Country (2021-2026)
  4. 8.1.3 Europe Alinia (nitazoxanide) Sales Forecast by Country (2027-2032)
  5. 8.2 Europe Alinia (nitazoxanide) Market Size by Country
  6. 8.2.1 Europe Alinia (nitazoxanide) Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 8.2.2 Europe Alinia (nitazoxanide) Market Size by Country (2021-2026)
  8. 8.2.3 Europe Alinia (nitazoxanide) Market Size Forecast by Country (2027-2032)
9 Asia-Pacific by Country
  1. 9.1 Asia-Pacific Alinia (nitazoxanide) Sales by Country
  2. 9.1.1 Asia-Pacific Alinia (nitazoxanide) Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 9.1.2 Asia-Pacific Alinia (nitazoxanide) Sales by Country (2021-2026)
  4. 9.1.3 Asia-Pacific Alinia (nitazoxanide) Sales Forecast by Country (2027-2032)
  5. 9.2 Asia-Pacific Alinia (nitazoxanide) Market Size by Country
  6. 9.2.1 Asia-Pacific Alinia (nitazoxanide) Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 9.2.2 Asia-Pacific Alinia (nitazoxanide) Market Size by Country (2021-2026)
  8. 9.2.3 Asia-Pacific Alinia (nitazoxanide) Market Size Forecast by Country (2027-2032)
10 South America by Country
  1. 10.1 South America Alinia (nitazoxanide) Sales by Country
  2. 10.1.1 South America Alinia (nitazoxanide) Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 10.1.2 South America Alinia (nitazoxanide) Sales by Country (2021-2026)
  4. 10.1.3 South America Alinia (nitazoxanide) Sales Forecast by Country (2027-2032)
  5. 10.2 South America Alinia (nitazoxanide) Market Size by Country
  6. 10.2.1 South America Alinia (nitazoxanide) Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 10.2.2 South America Alinia (nitazoxanide) Market Size by Country (2021-2026)
  8. 10.2.3 South America Alinia (nitazoxanide) Market Size Forecast by Country (2027-2032)
11 Middle East and Africa by Country
  1. 11.1 Middle East and Africa Alinia (nitazoxanide) Sales by Country
  2. 11.1.1 Middle East and Africa Alinia (nitazoxanide) Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 11.1.2 Middle East and Africa Alinia (nitazoxanide) Sales by Country (2021-2026)
  4. 11.1.3 Middle East and Africa Alinia (nitazoxanide) Sales Forecast by Country (2027-2032)
  5. 11.2 Middle East and Africa Alinia (nitazoxanide) Market Size by Country
  6. 11.2.1 Middle East and Africa Alinia (nitazoxanide) Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 11.2.2 Middle East and Africa Alinia (nitazoxanide) Market Size by Country (2021-2026)
  8. 11.2.3 Middle East and Africa Alinia (nitazoxanide) Market Size Forecast by Country (2027-2032)
12 Value Chain and Sales Channels Analysis
  1. 12.1 Alinia (nitazoxanide) Value Chain Analysis
  2. 12.1.1 Alinia (nitazoxanide) Key Raw Materials
  3. 12.1.2 Key Raw Materials Price
  4. 12.1.3 Raw Materials Key Suppliers
  5. 12.1.4 Manufacturing Cost Structure
  6. 12.1.5 Alinia (nitazoxanide) Production Mode & Process
  7. 12.2 Alinia (nitazoxanide) Sales Channels Analysis
  8. 12.2.1 Direct Comparison with Distribution Share
  9. 12.2.2 Alinia (nitazoxanide) Distributors
  10. 12.2.3 Alinia (nitazoxanide) Customers
13 Concluding Insights
    14 Appendix
    1. 14.1 Reasons for Doing This Study
    2. 14.2 Research Methodology
    3. 14.3 Research Process
    4. 14.4 Authors List of This Report
    5. 14.5 Data Source
    6. 14.5.1 Secondary Sources
    7. 14.5.2 Primary Sources
    8. 14.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,450USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst